Does MIRABEGRON Cause Basal cell carcinoma? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Basal cell carcinoma have been filed in association with MIRABEGRON (MIRABEGRON). This represents 0.0% of all adverse event reports for MIRABEGRON.
8
Reports of Basal cell carcinoma with MIRABEGRON
0.0%
of all MIRABEGRON reports
0
Deaths
5
Hospitalizations
How Dangerous Is Basal cell carcinoma From MIRABEGRON?
Of the 8 reports, 5 (62.5%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for MIRABEGRON.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which MIRABEGRON Alternatives Have Lower Basal cell carcinoma Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE